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ER–mitochondria associations are regulated by
the VAPB–PTPIP51 interaction and are disrupted
by ALS/FTD-associated TDP-43
Radu Stoica1,2,*, Kurt J. De Vos1,2,*,w, Se´bastien Paillusson1,2, Sarah Mueller1,2, Rosa M. Sancho1,2,w,
Kwok-Fai Lau1,w, Gema Vizcay-Barrena3, Wen-Lang Lin4, Ya-Fei Xu4, Jada Lewis4, Dennis W. Dickson4,
Leonard Petrucelli4, Jacqueline C. Mitchell2, Christopher E. Shaw2 & Christopher C.J. Miller1,2
Mitochondria and the endoplasmic reticulum (ER) form tight structural associations and
these facilitate a number of cellular functions. However, the mechanisms by which regions of
the ER become tethered to mitochondria are not properly known. Understanding these
mechanisms is not just important for comprehending fundamental physiological processes
but also for understanding pathogenic processes in some disease states. In particular,
disruption to ER–mitochondria associations is linked to some neurodegenerative diseases.
Here we show that the ER-resident protein VAPB interacts with the mitochondrial
protein tyrosine phosphatase-interacting protein-51 (PTPIP51) to regulate ER–mitochondria
associations. Moreover, we demonstrate that TDP-43, a protein pathologically linked to
amyotrophic lateral sclerosis and fronto-temporal dementia perturbs ER–mitochondria
interactions and that this is associated with disruption to the VAPB–PTPIP51 interaction
and cellular Ca2þ homeostasis. Finally, we show that overexpression of TDP-43 leads
to activation of glycogen synthase kinase-3b (GSK-3b) and that GSK-3b regulates the
VAPB–PTPIP51 interaction. Our results describe a new pathogenic mechanism for TDP-43.
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M
itochondria play pivotal roles in a number of cellular
processes including energy metabolism, Ca2þ home-
ostasis and lipid metabolism. These functions require a
dynamic spatial organization that permits relaying of signals
to and from other organelles. In particular, mitochondria are
associated with the endoplasmic reticulum (ER) with between 5
and 20% of the mitochondrial surface being closely apposed to ER
membranes1,2. The regions of ER associated with mitochondria
are termed mitochondria-associated ER membranes (MAMs) and
these contacts facilitate a variety of signalling processes between
the two organelles including Ca2þ and phospholipid exchange
(see reviews refs 3–5). Indeed, ER–mitochondria associations are
now believed to impact on a diverse number of physiological
processes including ATP production, autophagy, protein folding
in the ER, mitochondrial biogenesis and transport and
apoptosis4–8.
Despite their fundamental importance to cell metabolism, the
mechanisms that mediate ER–mitochondria associations are not
properly understood. Electron microscopy (EM) studies reveal
the presence of tethers that link ER and mitochondria2 but the
biochemical makeup of these structures is not fully clear. In yeast,
proteins of the ER–mitochondria encounter structure act as a
molecular tether between ER and mitochondria, but orthologues
in higher eukaryotes have not so far been identiﬁed9. There
is evidence that mitofusin-2 links ER and mitochondria in
mammalian cells10 but EM studies reveal that ER and
mitochondria are adjoined by structures of differing length and
this suggests that a number of proteins can physically connect
these organelles2,4,5.
Recently, several studies have linked defective ER–mitochondria
interactions to some neurodegenerative diseases11–15.
Accumulations of TDP-43 are a common pathological feature
in a variety of neurodegenerative diseases including amyotrophic
lateral sclerosis (ALS) and fronto-temporal dementia (FTD)16.
The importance of TDP-43 in the disease process is highlighted
by the ﬁndings that mutations in the TDP-43 gene are causative
for some familial forms of ALS/FTD17. However, the mechanisms
by which TDP-43 contributes to the neurodegenerative process
are not properly understood and indeed, disruption to a variety of
physiological pathways have been implicated in the pathogenic
process (see reviews refs 18,19).
Recently, we identiﬁed the outer mitochondrial membrane
protein, protein tyrosine phosphatase-interacting protein-51
(PTPIP51) as a binding partner for the resident ER protein
vesicle-associated membrane protein-associated protein-B
(VAPB)20. Here, we show that the VAPB–PTPIP51 interaction
regulates ER–mitochondria associations. Moreover, we demon-
strate that expression of both wild-type and ALS/FTD-associated
mutant TDP-43 perturbs ER–mitochondria associations and that
this is accompanied by changes to the VAPB–PTPIP51
interaction. As such, our ﬁndings reveal a new mechanism for
controlling ER–mitochondria interactions and highlight ER–
mitochondria associations as a target for disruption by TDP-43.
Results
VAPB and PTPIP51 interact in a range of biochemical assays.
VAPB and PTPIP51 interact in a variety of biochemical assays,
and the region of PTPIP51 that mediates binding involves its
central coiled-coil domain (amino acids 84–174)20. To gain
insight into the domain(s) of VAPB involved in binding
PTPIP51, we generated glutathione S-transferase (GST) fusion
proteins comprising the entire VAPB cytoplasmic domain (amino
acids 1–220), its N-terminal major sperm protein domain (amino
acids 1–124), its central coiled-coil domain (amino acids
142–207) and sequences encompassing the C-terminal part of
VAPB (amino acids 89–207) and tested their abilities to bind to
PTPIP51 in pull-down assays from PTPIP51-transfected cells.
Only the entire VAPB cytoplasmic domain bound PTPIP51
(Fig. 1a). Hence, the entire cytoplasmic domain of VAPB is
required for binding to PTPIP51 or the interaction requires some
topographical conformation that is lost in the smaller VAPB
fragments. We also performed in vitro-binding studies with
puriﬁed VAPB and PTPIP51 cytoplasmic domains that were
generated in E. coli. PTPIP51 cytoplasmic domain (amino acids
36–470) was incubated with either GST or GST-VAPB and the
GST moiety used to isolate bound PTPIP51. GST-VAPB
cytoplasmic domain but not GST bound to PTPIP51 in these
assays (Fig. 1b). Together with our previous studies20, these
results demonstrate that VAPB interacts with PTPIP51 in a
number of different assays including in vitro assays in the absence
of other proteins.
VAPB and PTPIP51 mediate ER–mitochondria associations.
The binding of VAPB to PTPIP51 suggests that these proteins act
as tethers to link ER with mitochondria. We therefore monitored
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Figure 1 | Binding of VAPB to PTPIP51 requires its complete cytosolic domain. (a) Cells were transfected with either control empty vector (CTRL) or
HA-tagged PTPIP51 and the lysates then used in GST pull-down assays with either GST, GST-VAPB1-124 (the MSP domain), GST-VAPB89-207,
GST-VAPB142-207 (containing the coiled-coil domain) or GST-VAPB1-220 (the entire cytosolic domain) ‘baits’. PTPIP51 only bound GST-VAPB1-220.
Upper shows immunoblot of both lysates and GST pulldowns probed for PTPIP51 via the HA tag; lower shows Poncea red-stained blot of GST ‘baits’.
(b) VAPB and PTPIP51 cytosolic domains bind directly in vitro. PTPIP51 cytosolic domain (amino acids 36–470) produced in E. coli was incubated with
either GST or GST-VAPB1-220 (the entire cytosolic domain) and bound PTPIP51 detected by immunoblotting. Upper shows input and either GST or
GST-VAPB1-220 pulldown; lower shows Coomassie blue-stained gel of GST ‘baits’.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms4996
2 NATURE COMMUNICATIONS | 5:3996 | DOI: 10.1038/ncomms4996 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
how modulating VAPB and PTPIP51 expression affects
ER–mitochondria associations via EM in mouse NSC34 motor
neuron cells. We quantiﬁed ER–mitochondria associations by
determining the proportion of the mitochondrial surface that was
closely apposed (o30 nm) to ER. Such an approach has been
used by others21,22.
We ﬁrst reduced VAPB and PTPIP51 expression using short
interfering RNAs (siRNAs) and identiﬁed one potent mouse
VAPB siRNA and two PTPIP51 siRNAs. Consistent with
previous studies in HEK293 cells20, siRNA knockdown of
VAPB did not inﬂuence expression of PTPIP51 and
knockdown of PTPIP51 did not inﬂuence expression of VAPB
in NSC34 cells (Fig. 2a). Approximately 12% of the mitochondrial
surface was closely associated with ER in untreated and control
siRNA cells. However, siRNA knockdown of either VAPB or
PTPIP51 signiﬁcantly reduced these values (Fig. 2b). We also
monitored how loss of VAPB and PTPIP51 affected
ER–mitochondria associations in human HEK293 cells using
previously characterized siRNAs that involved different
sequences20. Again, depletion of VAPB and PTPIP51 reduced
ER–mitochondria associations (% mitochondrial surface closely
apposed to ER reduced by 29% in VAPB siRNA and 46% in
PTPIP51 siRNA-treated cells compared with control siRNA cells.
Control vs VAPB siRNA Po0.05; control vs PTPIP51 siRNA
Po0.001. Data analysed by one-way analysis of variance and
Tukey’s multiple comparison test. N¼ 22 cells for each treatment
and 245–352 mitochondria).
We next elevated the expression of VAPB and PTPIP51 via
transfection. Cells were transfected with either enhanced cyan
ﬂuorescent protein (ECFP) control vector, ECFP-VAPB or
PTPIP51 that was expressed using a bicistronic internal ribosome
entry site vector with AcGFP. The ECFP/AcGFP tags were then
utilized to isolate transfected cells using a cell sorter. The
proportion of the mitochondrial surface closely associated with
ER in control cells expressing ECFP alone was not signiﬁcantly
different to that in untreated cells or cells treated with control
siRNA (Fig. 3a). However, expression of VAPB or PTPIP51
markedly increased ER–mitochondria associations (Fig. 3a). We
also monitored the effect of co-transfecting both VAPB and
PTPIP51 and obtained a remarkable phenotype where large
proportions of the mitochondrial surface were closely associated
with ER (Fig. 3a,b). Analyses of these images revealed the
presence of structures that appeared to tether ER with
mitochondria (Fig. 3c); the average spacing between ER and
mitochondria in the VAPBþPTPIP51 co-transfected cells
was 14.7 nm.
Confocal microscopy has also been utilized to study
ER–mitochondria interactions (for example, refs 1,10). Since
overexpressing VAPB and PTPIP51 produced particularly
striking EM images, we reasoned that such phenotypes would
be clearly discernible by light microscopy. We therefore
monitored the effect of transfecting VAPB and/or PTPIP51 on
ER mitochondria co-localization by confocal microscopy.
For these investigations, we utilized CV1 cells since these have
a ﬂattened and spread morphology, which facilitates such
morphological analyses. Cells were transfected with ECFP
control, ECFP-VAPB, haemagglutin-tagged PTPIP51 (PTPIP51-
HA) or ECFP-VAPBþPTPIP51-HA, and ER and mitochondria
co-localization monitored by immunostaining. ER was detected
by labelling for protein disulphide isomerase (PDI) and
mitochondria by labelling for translocase of the outer
mitochondrial membrane protein-20 (TOM20). Transfection of
VAPB and/or PTPIP51 all noticeably increased co-localization
of ER and mitochondria and in agreement with the EM studies,
this phenotype was particularly striking in VAPBþ PTPIP51
co-transfected cells (Fig. 4). To obtain unbiased quantitative data
on the effects of VAPB and PTPIP51 overexpression on
ER–mitochondria co-localization, we used intensity correlation
analysis (ICA) to analyse the co-localization of PDI and TOM20
signals in the different samples23. ICA is one of the most rigorous
methods for studying co-localization of proteins by confocal
microscopy since it compares the scatter plots of two stains
against the product of the difference of the pixel intensities of
each of the two stains from their respective means. Thus, unlike
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Figure 2 | siRNA knockdown of VAPB or PTPIP51 reduces
ER–mitochondria associations in NSC34 cells. (a) Immunoblots showing
siRNA knockdown of VAPB and PTPIP51. siRNA knockdown of VAPB does
not affect expression of PTPIP51, siRNA knockdown of PTPIP51 does not
affect expression of VAPB and siRNA knockdown of either VAPB or PTPIP51
does not affect expression of mitofusin-2 (MFN2). Also shown is an
immunoblot of tubulin as a loading control. (b) Representative electron
micrographs of ER–mitochondria associations in untreated cells and control
(CTRL), VAPB or PTPIP51 siRNA-treated cells; arrowheads with loops show
regions of association. Scale bar, 100 nm. Bar chart shows % of the
mitochondrial surface closely apposed to ER in the different samples.
Data were analysed by one-way analysis of variance followed by Tukey’s
multiple comparison test. N¼ 27–35 cells and 279–374 mitochondria;
error bars are s.e.m.; ***Po0.001.
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other methods, which simply compare co-localization of pixels,
ICA also determines whether the pixel intensities from the two
signals vary in synchrony. ICA yields an intensity correlation
quotient, which is a statistically testable single-value assessment of
the relationship between two stained protein pairs23. Transfection
of VAPB, PTPIP51 and VAPBþ PTPIP51 all signiﬁcantly
increased co-localization of ER and mitochondria in these
assays (Fig. 4). Thus, modulating VAPB and PTPIP51
expression signiﬁcantly inﬂuences ER–mitochondria interactions
in both EM and confocal light microscopy assays.
TDP-43 disrupts ER–mitochondria associations. We next
enquired whether expression of ALS/FTD-associated TDP-43
inﬂuenced ER–mitochondria associations. To do so, we trans-
fected NSC34 cells with EGFP control vector, EGFP-TDP-43, or
familial ALS mutant EGFP-TDP-43M337V, TDP-43Q331K,
TDP-43A382T or TDP-43G348C. Transfected cells were again
isolated using a cell sorter via the EGFP tags and ER–
mitochondria associations were quantiﬁed by EM as described
above. We detected no change in the numbers of mitochondria or
ER proﬁles in the presence of either wild-type or mutant TDP-43.
However, expression of both wild-type and mutant TDP-43 all
led to signiﬁcant reductions in ER–mitochondria associations
(Fig. 5a). The ﬁnding that both wild-type TDP-43 and mutant
TDP-43 disrupted ER–mitochondria interactions is consistent
with the phenotypes seen in transgenic mice, where expression of
both wild-type and mutant TDP-43 all induce disease24–28.
We also enquired whether siRNA-mediated loss of TDP-43
inﬂuenced ER–mitochondria associations or the VAPB–PTPIP51
interaction. However, loss of TDP-43 had no effect on either of
these (Fig. 6).
We next monitored whether transfection of wild-type or
mutant TDP-43 inﬂuenced expression of VAPB, PTPIP51
or mitofusin-2, a further protein that has been linked to
ER–mitochondria associations10. To do so, cell-sorted control
EGFP and EGFP-TDP-43-transfected cell proteins were probed
on immunoblots for VAPB, PTPIP51 and mitofusin-2. However,
no differences in expression of any of these proteins were detected
in the different samples (Fig. 5b). Thus, the reduction in
ER–mitochondria interactions seen in cells expressing wild-type
TDP-43 or mutant TDP-43 is not due to changes in expression of
VAPB, PTPIP51 or mitofusin-2.
To complement the above studies, we also quantiﬁed
ER–mitochondria associations in spinal cord motor neurons of
1-month-old homozygous TDP-43 transgenic and their non-
transgenic littermates26. At this age, these TDP-43 transgenic
mice develop motor defects and symptoms characteristic
of ALS26. Similar to control NSC34 cells, B12% of the
mitochondrial surface was closely apposed to ER in the non-
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Figure 3 | Overexpression of VAPB and/or PTPIP51 increases ER–mitochondria associations in NSC34 cells. (a) Representative electron micrographs of
ER–mitochondria associations in cells transfected with control ECFP vector (CTRL), ECFP-VAPB (VAPB), PTPIP51 (PTPIP51) or ECFP-VAPBþ PTPIP51;
arrowheads with loops show regions of association. (b) Low-magniﬁcation electron micrograph of cells co-transfected with VAPB and PTPIP51 to show
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associations of ER and mitochondria (Mit) as indicated with putative connections (arrowheads) linking ER with the outer mitochondrial membrane. Bar
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transgenic animals. However, in TDP-43 transgenic mice,
ER–mitochondria interactions were signiﬁcantly reduced (Fig. 5c).
TDP-43 disrupts VAPB–PTPIP51 interactions. Since VAPB
and PTPIP51 mediate ER–mitochondria associations, and since
expression of TDP-43 disrupted ER–mitochondria associations,
we enquired whether the expression of TDP-43 inﬂuenced
binding of VAPB to PTIP51. To do so, we transfected NSC34
cells with PTPIP51-HA and either EGFP control vector or
wild-type or ALS mutants of EGFP-TDP-43, and monitored
the amounts of endogenous VAPB bound to PTPIP51-HA in
immunoprecipitation assays. Consistent with the EM studies,
expression of both wild-type and ALS mutant TDP-43 all reduced
the amount of VAPB that was bound to PTPIP51 (Fig. 7a).
We obtained similar results in HEK293 cells (Fig. 7b).
We also monitored the effect of TDP-43 on the VAPB–
PTPIP51 interaction in TDP-43 transgenic mice using immuno-
precipitation assays. In spinal cords, endogenous VAPB bound to
endogenous PTPIP51 in these assays (Fig. 7c), which is consistent
with previous results on endogenous VAPB–PTPIP51 binding in
other tissues20. In line with the data from the TDP-43-transfected
NSC34 cells, no differences in the levels of VAPB, PTPIP51
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or mitofusin-2 were detected in spinal cords of TDP-43 and
non-transgenic mice (Fig. 7d). However, the amounts of PTPIP51
bound to VAPB were signiﬁcantly reduced in the TDP-43
transgenic mice (Fig. 7d). Thus, expression of ALS/FTD-
associated TDP-43 disrupts ER–mitochondria interactions and
this is associated with a decrease in the binding of VAPB
to PTPIP51.
Overexpression of TDP-43 disturbs cellular Ca2þ homeostasis.
Both ER and mitochondria are stores for intracellular Ca2þ and
the ER–mitochondria interface, and MAMs regulate Ca2þ
exchange between the two organelles1,2,10,20. Indeed, we have
shown that siRNA loss of VAPB and PTPIP51 perturbs cellular
Ca2þ homeostasis following its release from ER stores20. The
TDP-43-induced disruption to the VAPB–PTPIP51 interaction
and ER–mitochondria associations thus predict that TDP-43 may
inﬂuence Ca2þ homeostasis. We therefore monitored the effect
of overexpressing TDP-43 on cytosolic and mitochondrial Ca2þ
levels after induction of inositol 1,4,5-trisphosphate receptor
(IP3R)-mediated Ca2þ release from ER stores. For these
experiments, we used HEK293 cells co-transfected with the M3
VAPB
Input IP
25
75
50
25
75
0.0
0.5
R
el
at
ive
 
VA
PB
 le
ve
ls
1.0
1.5
50
0.0
0.5
1.0
1.5
R
el
at
ive
 V
AP
B 
le
ve
ls
EV CT
RL
TD
P-4
3
M3
37
V
A3
82
T
G3
48
C
Q3
31K
EV CT
RL
TD
P-4
3
M3
37
V
A3
82
T
G3
48
C
Q3
31K
CT
RL
TD
P-4
3
M3
37
V
A3
82
T
G3
48
C
Q3
31K
CT
RL
NT
g
TD
P-4
3
TD
P-4
3
M3
37
V
A3
82
T
G3
48
C
Q3
31K
PTPIP51
TDP-43
VAPB
PTPIP51
Input IP
NTg TDP-43 NTg TDP-43
50
1.5
1.0
0.5
R
el
at
ive
 
PT
PI
P5
1 
le
ve
ls
0.0
25
TDP-43
MFN2
37
75
37
Actin
VAPB
VAPB
PTPIP51
PTPIP51
150
100
75
50
37
25
TDP-43
Input
75
75
IP
EV
Inp
ut
–
Ab CT
RL
VA
PB
CT
RL
TD
P-4
3
M3
37
V
A3
82
T
G3
48
C
Q3
31K
EV CT
RL
TD
P-4
3
M3
37
V
A3
82
T
G3
48
C
Q3
31K
a
b
c d
Figure 7 | Expression of TDP-43 reduces the binding of VAPB to PTPIP51 in both transfected cells and transgenic mice. (a,b) Cells were transfected
with either empty vector (EV) or co-transfected with PTPIP51-HA and either EGFP control vector (CTRL) or wild-type or ALS/FTD mutants of TDP-43
(TDP-43M337V, TDP-43Q331K, TDP-43A382T and TDP-43G348C). PTPIP51 was immunoprecipitated using the HA tag and the amounts of endogenous
bound VAPB detected by immunoblotting. No signals were obtained for either VAPB or PTPIP51 in immunoprecipitations from EV-transfected cells, which
demonstrates the speciﬁcity of the immunoprecipitations. Both inputs and immunoprecipitations (IP) are shown. The bar chart shows relative levels
of VAPB bound to PTPIP51 in the immunoprecipitations following quantiﬁcation of signals from immunoblots. VAPB signals were normalized to
immunoprecipitated PTPIP51-HA signals. (a) Shows data for NSC34 cells; N¼ 3. (b) Shows data for HEK293 cells; N¼ 5. Data were analysed by one-way
analysis of variance and Tukey’s post hoc test; error bars are s.e.m., *Po0.05, **Po0.01. (c) VAPB binds to PTPIP51 in mouse spinal cords. VAPB was
immunoprecipitated using rabbit anti-VAPB and detected on immunoblots using rat anti-VAPB; bound PTPIP51 was detected using rat PTPIP51. Both inputs
and immunoprecipitations (IP) are shown. Control immunoprecipitations were performed using no primary antibody (Ab) or preimmune rabbit serum
(CTRL). (d) Reduced binding of VAPB to PTPIP51 in TDP-43 transgenic mice. Immunoprecipitations were performed as in c from three non-transgenic
(NTg) and three TDP-43 transgenic mice. Also shown are immunoblots for TDP-43, mitofusin-2 (MFN2) and actin as a loading control in the spinal cords.
Bar chart shows relative levels of PTPIP51 bound to VAPB in the immunoprecipitations following quantiﬁcation of signals from immunoblots. PTPIP51
signals were normalized to immunoprecipitated VAPB signals. Data were analysed by the unpaired t-test; error bars are s.e.m., **Po0.01.
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muscarinic-ACh-receptor (M3R) and either control vector or
TDP-43, and triggered physiological IP3R-mediated Ca2þ
release from ER stores by application of the M3R agonist
oxotremorine-M. In line with previous studies on VAPB,
PTPIP51 and ER–mitochondria associations, we used HEK293
cells for these experiments since they do not express endogenous
M3R and so provide a useful model for monitoring cytosolic and
mitochondrial Ca2þ levels after release from ER20. Transfection
of both wild-type and mutant TDP-43 all induced signiﬁcant
increases in cytosolic Ca2þ and decreases in mitochondrial Ca2þ
levels (Fig. 8). Such ﬁndings are consistent with the observed
TDP-43-induced decreases in ER–mitochondria and VAPB–
PTPIP51 interactions20.
TDP-43 activates GSK-3b to inhibit VAPB–PTPIP51 binding.
To gain insight into the mechanism by which TDP-43 might
inﬂuence the VAPB–PTPIP51 interaction, we ﬁrst tested whether
TDP-43 bound to either VAPB or PTPIP51. To do so, we per-
formed immunoprecipitation assays from TDP-43þVAPB and
TDP-43þPTPIP51-transfected cells. However, we did not detect
binding of TDP-43 to either protein in these assays (Fig. 9a) or in
yeast 2-hybrid library screens with VAPB or PTPIP51 baits20
(and our unpublished data). Others have also reported that
TDP-43 does not bind VAPB29.
Phosphorylation is a common mechanism for controlling
protein–protein interactions, and TDP-43 has recently been
shown to activate glycogen synthase kinase-3b (GSK-3b)30.
A major route for regulating GSK-3b is by inhibitory
phosphorylation of serine-9, and so we monitored GSK-3b
serine-9 phosphorylation in control and TDP-43-transfected cells
by immunoblotting. In agreement with previous studies30, we
found that overexpression of wild-type and four different TDP-43
mutants all activated GSK-3b as evidenced by reduced serine-9
phosphorylation (Fig. 9b). To determine whether GSK-3b might
regulate the VAPB–PTPIP51 interaction, we modulated GSK-3b
activity in transfected cells and monitored the effects on binding
of VAPB to PTPI51 again using immunoprecipitation assays.
Two structurally different GSK-3b inhibitors both increased,
whereas transfection of GSK-3b to elevate its activity31 reduced
binding of VAPB to PTPIP51 (Fig. 9c,d). Thus, TDP-43 activates
GSK-3b and GSK-3b regulates the VAPB–PTPIP51 interaction.
Discussion
Despite their fundamental importance to a variety of physiolo-
gical processes, the mechanisms that mediate and regulate ER–
mitochondria associations are not properly understood. Recently,
we demonstrated an interaction between the resident ER protein
VAPB and the mitochondrial protein PTPIP51 (ref. 20). VAPB is
anchored in the ER via a C-terminal membrane-spanning domain
such that its N terminus projects into the cytoplasm, and
PTPIP51 is an outer mitochondrial membrane protein whose C
terminus projects into the cytoplasm20. VAPB is also a MAM
protein20. VAPB and PTPIP51 interact in yeast 2-hybrid,
immunoprecipitation (including transfected and endogenous
proteins), GST pull-down assays and proximity ligation assays,
and recombinant VAPB and PTPIP51 cytoplasmic domains
interact in vitro in the absence of other proteins demonstrating
direct binding20 (and results presented here). Thus, VAPB
and PTPIP51 represent plausible candidates for mediating
ER–mitochondria interactions.
To directly test this possibility, we used EM to monitor
how modulating VAPB and PTPIP51 expression affects ER–
mitochondria associations. siRNA knockdown of VAPB or
PTPIP51 reduced, whereas overexpression of VAPB and/or
PTPIP51 markedly increased ER–mitochondria associations.
Indeed, overexpression of both VAPB and PTPIP51 produced a
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Figure 8 | Expression of TDP-43 disrupts cellular Ca2þ homeostasis. HEK293 cells were transfected with M3R and either control empty vector (CTRL),
TDP-43, TDP-43M337V, TDP-43Q331K, TDP-43A382T or TDP-43G348C as indicated. Release of ER Ca2þ was induced by treatment of cells with
Oxotremorine-M (OxoM). (a) shows cytosolic Ca2þ levels with representative Fluo4 ﬂuorescence traces on the left and normalized peak values on the
right. Fluo4 ﬂuorescence shows a transient increase in cytosolic Ca2þ levels upon OxoM treatment but compared with control, wild-type and mutant
TDP-43 all increase peak cytosolic Ca2þ levels. (b) shows mitochondrial Ca2þ levels with representative Rhod2 ﬂuorescence traces on the left and
normalized peak values on the right. Data were analysed by one-way analysis of variance and Tukey’s post hoc test. (a) N¼48–52 cells from 3–5
experiments; (b) N¼48–52 cells from 3–4 experiments. *Po0.05, ***Po0.001; error bars are s.e.m.
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Figure 9 | TDP-43 activates GSK-3b, and modulating GSK-3b activity regulates the VAPB–PTPIP51 interaction. (a) Immunoprecipitation assays of
TDP-43 with VAPB and PTPIP51. HEK293 cells were transfected with either VAPB (upper) or PTPIP51 (lower) and either control empty vector (EV) or
EGFP-tagged TDP-43, TDP-43M337V, TDP-43Q331K, TDP-43A382Tor TDP-43G348C. VAPB and PTPIP51 were immunoprecipitated via their myc or HA
tags and the samples probed for co-immunoprecipitating TDP-43 on immunoblots. (b) TDP-43 activates GSK-3b. HEK293 cells were transfected with
either control empty vector (CTRL), TDP-43, TDP-43M337V, TDP-43Q331K, TDP-43A382Tor TDP-43G348C and the samples probed on immunoblots for
total GSK-3b and GSK-3b phosphorylated on serine-9. Phosphorylation of GSK-3b serine-9 is the principal mechanism for regulating its activity; serine-9
phosphorylation inhibits GSK-3b activity. Bar chart shows relative levels of GSK-3b serine-9 phosphorylation following quantiﬁcation of signals from
immunoblots and normalization to total GSK-3b signals. Data were analysed by one-way analysis of variance (ANOVA) and Tukey’s post hoc test. N¼ 5;
*Po0.05, **Po0.01,***Po0.001; error bars are s.e.m.. (c) Inhibition of GSK-3b increases the amount of VAPB bound to PTPIP51. Cells were transfected
with control empty vector (EV) or HA-tagged PTPIP51 and treated with either vehicle, GSK-3b inhibitor AR-A014418 (1mM) or GSK-3b inhibitor CT99021
(100 nM) for 16 h. PTPIP51 was immunoprecipitated using the HA tag and the amounts of endogenous bound VAPB detected by immunoblotting. Both
inputs and immunoprecipitations (IP) are shown. Bar chart shows relative levels of VAPB bound to PTPIP51 in the immunoprecipitations following
quantiﬁcation of signals from immunoblots. VAPB signals were normalized to immunoprecipitated PTPIP51-HA signals. Data were analysed by one-way
ANOVA and Tukey’s post hoc test; N¼ 3, error bars are s.e.m., *Po0.05. (d) Transfection of GSK-3b decreases the amount of VAPB bound to PTPIP51. Cells
were transfected with empty vector (EV), HA-PTPIP51 or HA-PTPIP51þGSK-3b. PTPIP51 was immunoprecipitated using the HA tag and the amounts of
endogenous bound VAPB detected by immunoblotting. Both inputs and immunoprecipitations (IP) are shown. Bar chart shows relative levels of VAPB
bound to PTPIP51 in the immunoprecipitations following quantiﬁcation of signals from immunoblots. VAPB signals were normalized to immunoprecipitated
PTPIP51 signals. Data were analysed by the unpaired t-test; N¼ 3, error bars are s.e.m., *Po0.05.
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remarkable phenotype detectable by both EM and confocal
microscopy, in which ER and mitochondria redistribute to form
close associations. Alterations to ER–mitochondria interactions
inﬂuence Ca2þ exchange between these organelles, and we have
demonstrated previously that modulating VAPB and PTPIP51
expression induces such changes to Ca2þ homeostasis20.
Together, these ﬁndings support the conclusion that VAPB
and PTPIP51 form at least one of the scaffolds that mediate
ER–mitochondria associations.
Abnormal TDP-43 metabolism is strongly linked to both ALS
and FTD. Thus, mutations in TDP-43 cause some familial forms
of ALS and FTD, accumulations of TDP-43 are a hallmark
pathology of ALS/FTD and overexpression of both wild-type and
familial ALS-associated mutants of TDP-43 all induce disease
in transgenic rodents17,24–28,32. Despite these ﬁndings, the
mechanisms underlying TDP-43 toxicity are not properly
known. Although TDP-43 is a predominantly nuclear protein,
a proportion is normally present in the cytoplasm33–35.
Cytoplasmic TDP-43 is associated with mitochondria but
there is also evidence linking it with the ER35–39. Indeed,
several recent studies have linked TDP-43 toxicity with damage to
mitochondria26,28,35,40 and ER stress signalling pathways36–39.
Together, these ﬁndings suggest that the ER–mitochondria axis
may be perturbed by TDP-43.
In support of this notion, we show here that overexpression of
wild-type and mutant TDP-43 reduce ER–mitochondria interac-
tions, and that these reductions are associated with decreased
binding of VAPB to PTPIP51. We also demonstrate that TDP-43
increases cytosolic Ca2þ and decreases mitochondrial Ca2þ
levels following IP3R-mediated Ca2þ release from ER stores,
which is consistent with a decrease in ER–mitochondria
associations20. Our ﬁndings that overexpression of wild-type as
well as mutant TDP-43 affects ER-mitochondria associations, the
VAPB-PTPIP51 interaction and associated Ca2þ homeostasis are
consistent with many studies which show that wild-type as well as
mutant TDP-43 all induce similar, aggressive forms of disease in
transgenic mice and in other models (for example, refs 24–28,41).
Thus, ER–mitochondria and VAPB–PTPIP51 interactions may
be targets for damage by TDP-43. The precise mechanisms
underlying this damage are not clear. However, in agreement with
previous studies we show that overexpression of TDP-43 activates
GSK-3b a kinase strongly implicated in both ALS and
dementia30,42,43. Moreover, we demonstrate that modulating
GSK-3b activity affects the VAPB–PTPIP51 interaction;
inhibiting GSK-3b increased, whereas overexpression of GSK-
3b decreased binding of VAPB to PTPIP51. Thus, the effect of
TDP-43 on the VAPB–PTPIP51 interaction may involve
activation of GSK-3b, which then leads to decreased VAPB–
PTPIP51 binding. This may be via direct phosphorylation of
VAPB or PTPIP51 by GSK-3b to inhibit their binding, or
signalling via GSK-3b to downstream effectors that somehow
inﬂuences VAPB/PTPIP51 phosphorylation and/or binding.
Future studies to tackle this will involve mass spectrometric
sequencing of VAPB and PTPIP51 to identify any GSK-3b
phosphorylation sites, and the analyses of their function using
mutagenic approaches.
Disruptions to a number of physiological processes are seen in
both ALS and FTD. These include damage to mitochondria and
mitochondrial ATP production, disruption to Ca2þ homeostasis,
perturbation to axonal transport of mitochondria, damage to
autophagy and ﬁnally damage to the ER including activation of
the unfolded protein response (UPR) (see review (ref. 44)). One
conundrum is how so many apparently disparate pathological
features might link together in a common disease pathway.
However, all of these features are regulated by ER–mitochondria
associations. Thus ER–mitochondrial Ca2þ exchange following
release from ER stores affects both cellular Ca2þ homeostasis and
mitochondrial ATP production since several mitochondrial
dehyrogenase enzymes involved in ATP synthesis are Ca2þ
regulated4,45. Decreased mitochondrial ATP production is a
feature of at least some forms of ALS and FTD46. Likewise,
ER–mitochondria associations are linked to axonal transport.
Mitochondria are anterogradely transported through axons on
kinesin-1 motors and attach to kinesin-1 via the outer
mitochondrial membrane protein Miro, which acts as a Ca2þ
sensor; elevated Ca2þ levels disrupt transport47. Recently, Miro
has been shown to localize to ER–mitochondria contact sites and
a proportion of ER has been shown to be co-transported with
mitochondria48,49. Also, defects in autophagy are features of ALS/
FTD involving TDP-43; autophagosomes are now known to form
at ER–mitochondria contacts7,50,51. Finally, ER–mitochondria
associations impact on ER stress and the UPR since a number of
ER chaperones involved in protein folding localize to MAM and
structural uncoupling of ER from mitochondria induces ER stress
and ER-UPR3,52. Indeed, VAPB itself is linked to the UPR
(see review (ref. 53)). Thus, the TDP-43 loosening of
ER–mitochondria associations that we described here may
contribute to some of the pathological features of ALS/FTD.
Several recent studies have implicated defective
ER–mitochondria signalling in some related neurodegenerative
diseases including Alzheimer’s and Parkinson’s diseases11–15,54.
Damage to the ER–mitochondria axis may thus be a common
feature of neurodegenerative diseases. The results described here,
which show that VAPB and PTPIP51 function to mediate
ER–mitochondria associations and which demonstrate that the
VAPB–PTPIP51 interaction is disrupted by TDP-43, will
facilitate future studies on the role of ER–mitochondria
associations in neurodegenerative diseases.
Methods
Plasmids and siRNAs. Mammalian expression vectors were HA-tagged PTPIP51
in pCIneo, ECFP-tagged VAPB in pECFP-C1, M3R, EGFP-tagged wild-type
TDP-43 and mutants TDP-43Q331K and TDP-43M337V in pEGFP-C120,55,56.
TDP-43A382T and TDP-43G348C mutants were created using a QuikChange XL
mutagenesis kit (Stratagene). Mutagenic primers were: TDP-43A382T 50-GGCTCT
AATTCTGGTGCAACAATTGGTTGGGG-30 and 50-CCCCAACCAATTGTTG
CACCAGAATTAGAGCC-30 ; TDP-43G348C 50-GCAGAACCAGTCATGCCCA
TCGGGTAATAACC-30 and 50-GGTTATTACCCGATGGGCATGACTGGTTC
TGC-30 . PTPIP51 was cloned into the internal ribosome entry site vector pIRES2-
AcGFP1. GST-VAPB and GST-PTPIP51 fusion plasmids were created by
amplifying appropriate VAPB and PTPIP51 sequences by PCR and cloning into
pGEX5X (GE Healthcare). Control, VAPB and PTPIP51 siRNAs were from
Dharmacon and Origene. Mouse siRNA sequences for NSC34 cells were: VAPB
50-UGUUACAGCCUUUCGAUUAUU-30; PTPIP51 50-GGAUGACAACGCUG
GCAAAGGGUCU-30 and 50-AGGUUAUACAACAGCCAACGCGGAG-30;
TDP-43 50-CGAUGAACCCAUUGAAAUA-30 and 50-GGAGAGGAUUUGAUCA
UUA-30 . Human VAPB and PTPIP51 siRNAs for HEK293 cells were: VAPB
50-GCUCUUGGCUCUGGUGGUUUU-30; PTPIP51 50-CCUUAGACCUUGCU
GAGAUUU-30 (see (ref. 20)).
Antibodies and inhibitors. Rat and rabbit antibodies to VAPB and PTPIP51 were
generated by immunization with GST-VAPB(1–220) and GST-PTPIP51(36–470),
respectively20. Rabbit anti-PTPIP51 was from Atlas, rabbit anti-haemagglutin
(HA), mouse anti-a-tubulin (DM1A) and rabbit anti-Mitofusin-2 were from
Sigma. Rabbit anti-TOM20 was from Santa Cruz Biotechnology. Rabbit anti-GFP
and mouse anti-bactin were from Abcam. Mouse PDI (RL77) was from Afﬁnity
Bioreagents. Rabbit anti-TDP-43 (12892-1-AP) was from Proteintech. Antibodies
to total and ser9-phosphorylated (inactive) GSK-3b were from BD Transduction
Labs (mouse 610201) and Cell Signalling (rabbit 9336), respectively. The
concentrations used for the different antibodies are shown in Supplementary
Table 1. Secondary antibodies were horseradish peroxidase-coupled goat anti-
mouse, anti-rabbit and anti-rat Igs (GE Healthcare), and Alexa ﬂuorophore
(350, 488 and 568)-coupled goat anti-mouse and anti-rabbit IgGs (Invitrogen).
AR-A014418 and CT99021 were from Abcam and Cayman, respectively.
Cell culture and transfection. NSC34 cells were provided by Professor Dame
Pamela Shaw, (University of Shefﬁeld, UK). CV1 and HEK293 cells were obtained
from the ATCC. Cells were grown in Dulbecco’s modiﬁed Eagle’s medium
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containing 10% fetal bovine serum supplemented with 2mM glutamine. NSC34
and HEK293 cells were transfected using Lipofectamine 2000 (Invitrogen); CV1
cells were transfected using Exgen (Fermentas) according to the manufacturer’s
instructions. Transfected cells were analysed 36 h post transfection; siRNA-treated
cells were analysed 4 days post treatment. For ﬂuorescence-activated ﬂow cyto-
metry cell sorting, NSC34 were trypsinized, resuspended in phosphate-buffered
saline (PBS) and then sorted for ECFP and EGFP expression using a BD FACSAria
cell sorter, re-plated and cultured for a further 16 h before processing.
Electron and light microscopy. For EM, NSC34 cells were ﬁxed with 2.5% glu-
taraldehyde in 0.1M sodium cacodylate buffer (pH 7.2) for 3 h and then harvested
by scraping gently with a plastic scraper. The cells were pelleted by centrifugation
at 800g(av) for 10min, washed in buffer and post-ﬁxed for 1 h in 1% osmium
tetroxide in 0.1M sodium cacodylate buffer. The cells were then stained for 1 h
with 1% uranyl acetate in water before dehydration and embedding in Taab resin.
Spinal cords from 4% paraformaldehyde-perfused mice were immersed in 2.5%
glutaraldehyde in 0.1M sodium cacodylate buffer, post-ﬁxed in 1% osmium
tetroxide, dehydrated in alcohol and propylene oxide and ﬁnally inﬁltrated and
embedded in Epon 812 (ref. 26). Samples were viewed on a Tecnai 12 electron
microscope at 6,800 or 23,000 magniﬁcation. Digital images were acquired and the
circumference of each mitochondria and the proportions of the mitochondrial
surface (circumference) closely associated (o30 nm) with ER were calculated.
Cells were randomly selected for analyses without prior knowledge of transfected
plasmid, siRNA or mouse genotype. All clearly identiﬁed mitochondria in the
samples were scored. Image analyses were performed using Adobe Illustrator
and ImageJ.
For immunostaining of CV1 cells, cells were ﬁxed in 4% paraformaldehyde/
0.1% glutaraldehyde in PBS, quenched in 0.05M ammonium chloride in PBS and
permeabilized with 0.25% Triton X-100 in PBS. Following blocking in 3% bovine
serum albumin in PBS, samples were incubated with primary antibodies diluted in
blocking solution, washed with PBS and incubated with secondary antibodies.
Following washing, the samples were mounted in Mowiol-DABCO mounting
medium containing 10% (w/v) Mowiol 4–88 (Calbiochem), 25% (w/v) glycerol and
2.5% (w/v) DABCO (1,4-diazobicyclo[2.2.2]octane) in 100mM Tris–HCl pH 8.5.
Cells were imaged using a Zeiss LSM510Meta confocal microscope equipped with a
 63 Plan-Apochromat 1.4 NA objective and analysed using ImageJ with the ICA
plug-in57. Statistical analyses were performed using GraphPad Prism.
SDS-PAGE, immunoblotting, immunoprecipitation and GST assays. Cells were
harvested for SDS-PAGE and immunoblotting by scraping into SDS–PAGE sample
buffer containing 2% SDS, 100mM dithiothreitol, 10% glycerol, 0.1% bromophenol
blue and protease inhibitors (Complete Roche) in 50mM Tris–HCl pH 6.8 and
heating to 100 C for 5min57. For immunoprecipitation assays, transfected
HEK293 cells were lysed in ice-cold immunoprecipitation buffer comprising
50mM Tris-citrate pH 7.4, 150mM NaCl, 1% Triton X-100, 5mM ethylene glycol
tetraacetic acid, 5mM EDTA and protease inhibitors (Complete, Roche) for
30min. Transgenic mouse samples were homogenized and diluted into the same
buffer. NSC34 cells were lysed in RIPA buffer containing 25mM Tris–HCl pH 7.5,
1% NP-40, 1% sodium deoxycholate, 0.1% SDS, 150mM NaCl and protease
inhibitors (Complete Roche). The samples were then centrifuged at 13,000g for
20min and the supernatants were transferred to fresh tubes and precleared by
incubation with Protein-G-sepharose beads (prepared as a 50% slurry in PBS
containing 0.1% Triton X-100). Following centrifugation at 2,000 g for 30 s to settle
the beads, supernatants were transferred to fresh tubes and protein concentrations
determined using a Bio-Rad protein assay kit. The protein concentrations were
adjusted to 1 mg ml 1, and 500 mg protein incubated with appropriate primary
antibodies on a rotary shaker for 16 h at 4 C. Antibodies were then captured by
addition of 30 ml Protein-G-sepharose beads (50% slurry in PBS/0.1% Triton
X-100). Following washing in PBS/0.1% Triton X-100, bound proteins were
prepared for SDS–PAGE by addition of 50 ml SDS-PAGE sample buffer and
heating to 100 C. Signals on immunoblots were quantiﬁed using ImageJ after
scanning with an Epson Precision V700 Photo scanner essentially as described by
us in previous studies57. To ensure the signals obtained were within the linear
range, the mean background-corrected optical density (OD) of each signal was
interpolated for an OD calibration curve created using a calibrated OD step tablet
(Kodak). Only ﬁlm exposures that gave OD signals within the linear range of the
OD calibration curve were used for the statistical analyses.
GST, GST-VAPB and GST-PTPIP51 fusion proteins were prepared on
glutathione-sepharose beads from E. coli BL21(DE3) according to the
manufacturer’s instructions (GE Healthcare). For cellular pull-down assays, GST
and GST fusion proteins were incubated with transfected cell lysates prepared in
immunoprecipitation buffer as described above58. For in vitro pull-down assays
of recombinant VAPB and PTPIP51, the cytoplasmic domain of PTPIP51
(aa36–470), was prepared as a GST fusion protein and PTPIP51(36–470) released
from the GST moiety by incubating GST-PTPIP51(36–470) bound to glutathione-
sepharose beads with 1 mg factor XA protease in 50ml buffer containing 20mM
Tris–HCl pH 8.0, 100mM NaCl, 2mM CaCl2 for 16 h at 4 C according to the
manufacturer’s recommendations (New England Biolabs). 50 mg of puriﬁed
recombinant PTPIP51(36-470) was then incubated for 16 h at 4 C with either GST
or GST-VAPB(1–220) fusion proteins on glutathione-sepharose beads in PBS
containing 1% Triton X-100. GST-fusion protein complexes were pelleted and
washed three times with incubation buffer by centrifugation at 2,000 g for 30 s, and
analysed by SDS-PAGE and immunoblotting as described above.
Full blots are shown in Supplementary Fig. 1.
Ca2þ measurements. Cytosolic and mitochondrial Ca2þ levels were measured
following IP3R-mediated release from ER stores in HEK293 cells20. To do so, cells
transfected with M3R and either empty vector control plasmid or TDP-43 plasmids
were loaded with either 2 mM Fluo4-AM or Rhod2-AM dye (Invitrogen) in external
solution (145mM NaCl, 2mM KCl, 5mM NaHCO3, 1mM MgCl2, 2.5mM CaCl2,
10mM glucose and 10mM Na-HEPES pH 7.25) containing 0.02% Pluronic-F27
(Invitrogen) for 15min at 37 C, followed by washing in external solution for
15min. Fluo4 and Rhod2 ﬂuorescence were timelapse recorded (1-s intervals) with
MetaMorph (Molecular Dynamics) on an Axiovert S100 microscope (Zeiss)
equipped with appropriate ﬁltersets (Chroma Technology), a  40/1.3NA Plan-
Neoﬂuar objective (Zeiss) and a Photometrics Cascade-II 512B EMCCD. The cells
were kept under constant perfusion with external solution (0.5mlmin 1). IP3R-
mediated Ca2þ release from ER stores was triggered by application of 100mM
Oxotremorine-M (Tocris) for 2min. Ca2þ levels were calculated as relative Fluo4
or Rhod2 ﬂuorescence compared with baseline ﬂuorescence at the start of the
measurement.
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